Sanofi: No 'major' U.S. deal presented to board

Hearing rumors that Sanofi-Aventis was looking at a "major" U.S. acquisition? Well, Sanofi denied it presented said acquisition plan to its board, after Les Echos newspaper reported that the drugmaker's major shareholders had deemed the deal too risky. Report

Suggested Articles

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.

After Merck and Bayer's vericiguat scored in a heart failure trial, you'd expect potential rivals to brace themselves. Not so for Novartis'…